Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Kairos Pharma (KAPA) Equity Ratio (2024 - 2025)

Historic Equity Ratio for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to 0.9.

  • Kairos Pharma's Equity Ratio changed N/A to 0.9 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.9, marking a year-over-year change of. This contributed to the annual value of 0.83 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Kairos Pharma reported Equity Ratio of 0.9 as of Q2 2025.
  • Kairos Pharma's 5-year Equity Ratio high stood at 0.9 for Q2 2025, and its period low was 0.67 during Q3 2024.